John Wiley & Sons (NYSE:WLYB) Downgraded to C at TheStreet

TheStreet lowered shares of John Wiley & Sons (NYSE:WLYBGet Rating) from a b- rating to a c rating in a report published on Wednesday, TheStreetRatingsTable reports.

John Wiley & Sons Stock Performance

WLYB stock opened at $41.46 on Wednesday. John Wiley & Sons has a 12 month low of $41.46 and a 12 month high of $60.00. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.53 and a current ratio of 0.64. The business’s 50-day moving average price is $48.81. The stock has a market cap of $2.31 billion, a PE ratio of 20.13 and a beta of 0.72.

John Wiley & Sons (NYSE:WLYBGet Rating) last released its quarterly earnings data on Wednesday, June 15th. The company reported $1.08 earnings per share (EPS) for the quarter. The company had revenue of $545.65 million during the quarter. John Wiley & Sons had a net margin of 5.60% and a return on equity of 18.61%.

John Wiley & Sons Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 20th. Shareholders of record on Wednesday, July 6th were given a $0.3475 dividend. This represents a $1.39 annualized dividend and a yield of 3.35%. This is a boost from John Wiley & Sons’s previous quarterly dividend of $0.35. The ex-dividend date was Tuesday, July 5th. John Wiley & Sons’s payout ratio is 50.00%.

About John Wiley & Sons

(Get Rating)

John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research Publishing & Platforms, Academic & Professional Learning, and Education Services. The Research Publishing & Platforms segment offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.

Featured Stories

Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with's FREE daily email newsletter.